Organigram Launches FAST™ Nanoemulsion Gummies
Organigram Holdings (NASDAQ: OGI) has launched Edison Sonics gummies, featuring their innovative FAST™ (Fast Acting Soluble Technology) nanoemulsion technology. The product delivers up to ~50% faster onset and nearly double the cannabinoids at peak effect compared to traditional edibles, as verified through pharmacokinetic studies completed in January 2024.
The gummies will be available in two flavors: Kiwi Berry Burst (Sativa) and Red Razz Chiller (Indica), each pack containing two gummies with 5mg THC + 5mg CBD per gummy. The product will be available in major provinces starting early December.
Organigram Holdings (NASDAQ: OGI) ha lanciato caramelle Edison Sonics, caratterizzate dalla loro innovativa tecnologia di nanoemulsione FAST™ (Fast Acting Soluble Technology). Il prodotto offre un'inizio effetto fino a ~50% più rapido e quasi il doppio dei cannabinoidi al picco dell'effetto rispetto ai dolcetti tradizionali, come confermato da studi farmacocinetici completati a gennaio 2024.
Le caramelle saranno disponibili in due gusti: Kiwi Berry Burst (Sativa) e Red Razz Chiller (Indica), ogni confezione contiene due caramelle con 5mg di THC + 5mg di CBD per caramella. Il prodotto sarà disponibile nelle province principali a partire dai primi di dicembre.
Organigram Holdings (NASDAQ: OGI) ha lanzado gominolas Edison Sonics, que cuentan con su innovadora tecnología de nanoemulsión FAST™ (Fast Acting Soluble Technology). El producto ofrece un inicio de efecto hasta ~50% más rápido y casi el doble de cannabinoides en el pico de efecto en comparación con los comestibles tradicionales, según lo verificado a través de estudios farmacocinéticos completados en enero de 2024.
Las gominolas estarán disponibles en dos sabores: Kiwi Berry Burst (Sativa) y Red Razz Chiller (Indica), cada paquete contiene dos gominolas con 5mg de THC + 5mg de CBD por gominola. El producto estará disponible en las principales provincias a partir de principios de diciembre.
Organigram Holdings (NASDAQ: OGI)가 Edison Sonics 구미를 출시했습니다. 이 제품은 혁신적인 FAST™ (Fast Acting Soluble Technology) 나노 에멀전 기술을 특징으로 합니다. 이 제품은 기존 식품에 비해 ~50% 더 빠른 시작 효과를 제공하며, 피크 효과에서 거의 두 배의 칸나비노이드를 함유하고 있다는 것이 2024년 1월에 완료된 약리학적 연구를 통해 확인되었습니다.
구미는 두 가지 맛으로 제공됩니다: Kiwi Berry Burst (Sativa)와 Red Razz Chiller (Indica). 각 팩에는 5mg THC + 5mg CBD가 들어 있는 두 개의 구미가 포함되어 있습니다. 이 제품은 12월 초부터 주요 지방에서 구입할 수 있습니다.
Organigram Holdings (NASDAQ: OGI) a lancé les gommes Edison Sonics, qui intègrent leur technologie d'émulsion nano FAST™ (Fast Acting Soluble Technology) innovante. Le produit permet un début d'effet jusqu'à ~50% plus rapide et presque le double des cannabinoïdes au pic d'effet par rapport aux aliments traditionnels, comme le confirme des études pharmacocinétiques terminées en janvier 2024.
Les gommes seront disponibles en deux saveurs : Kiwi Berry Burst (Sativa) et Red Razz Chiller (Indica), chaque paquet contenant deux gommes avec 5mg de THC + 5mg de CBD par gomme. Le produit sera disponible dans les principales provinces à partir début décembre.
Organigram Holdings (NASDAQ: OGI) hat Edison Sonics Gummies auf den Markt gebracht, die mit ihrer innovativen FAST™ (Fast Acting Soluble Technology) Nanoemulsionstechnologie ausgestattet sind. Das Produkt bietet einen Wirkungseintritt, der bis zu ~50% schneller ist, und fast doppelt so viele Cannabinoide zum Höchstwert im Vergleich zu herkömmlichen Lebensmitteln, wie durch pharmakokinetische Studien, die im Januar 2024 abgeschlossen wurden, bestätigt wurde.
Die Gummies werden in zwei Geschmacksrichtungen erhältlich sein: Kiwi Berry Burst (Sativa) und Red Razz Chiller (Indica), jede Packung enthält zwei Gummies mit jeweils 5mg THC + 5mg CBD. Das Produkt wird ab Anfang Dezember in den wichtigsten Provinzen erhältlich sein.
- Launch of innovative FAST™ technology proven to deliver 50% faster onset
- Clinical validation through large-scale pharmacokinetic studies
- Patent-pending technology showing improved bioavailability
- Nearly double cannabinoid delivery at peak effect compared to traditional edibles
- None.
Insights
The launch of Edison Sonics gummies with FAST™ nanoemulsion technology represents a significant technological breakthrough in the cannabis edibles market. The clinically proven ~50% faster onset time and doubled cannabinoid delivery at peak effect addresses two major consumer pain points in the edibles category - onset time and bioavailability. This proprietary technology creates a meaningful competitive advantage in the
The product's dual THC+CBD formulation at 5mg+5mg per piece targets the growing balanced-effects segment. The patent-pending status of FAST™ technology provides intellectual property protection and potential licensing opportunities. With distribution secured across major provinces and a December launch timeline, this innovation could significantly impact Organigram's market share in the edibles category, which has been showing strong growth.
This product launch is strategically timed to capitalize on the growing consumer demand for fast-acting cannabis products. The extensive pharmacokinetic study backing the technology adds scientific credibility that differentiates it from competitors' claims. The two flavor profiles and balanced THC:CBD ratio target both recreational and wellness consumers - a calculated move to maximize market penetration.
Building on Edison's successful track record with innovations like JOLTS, this launch strengthens Organigram's position in the premium segment. The emphasis on scientific validation and controlled dosing aligns with evolving consumer preferences for predictable experiences. This could drive meaningful revenue growth given edibles' higher margins compared to flower products.
- Company Continues to Lead in Innovation with Launch of Edison Sonics Gummies Featuring Groundbreaking FAST™ Nanoemulsion Technology
-
Clinically Proven to Deliver up to ~
50% Faster Onset, Improved Bioavailability and Nearly Double the Cannabinoid Delivery at Peak Effect
(Graphic: Business Wire)
FAST™ products deliver up to ~
The groundbreaking patent-pending technology, branded FAST ™ (Fast Acting Soluble Technology), is the first innovation to be commercialized by Organigram leveraging the output of the Product Development Collaboration (“PDC”), established to focus on developing next-generation cannabis products.
“We pride ourselves on consistently being at the forefront of cannabis innovation, pushing boundaries to deliver products that resonate with consumers while firmly being grounded in science and research-based technology,” said Borna Zlamalik, Senior Vice President, R&D and Innovation at Organigram. “We are extremely excited about this launch as our Edison Sonics gummies will be a game-changer in the edibles category and FAST™ will redefine how consumers experience cannabis. We are thrilled to be leading the charge in transforming the way cannabis is enjoyed.”
Edison Sonics are launching with two exciting flavours and will be available in all major provinces starting early December:
- Kiwi Berry Burst (Sativa) – Strawberry, Kiwi, Passionfruit
- Red Razz Chiller (Indica) – Raspberry, Pomelo
Each pack will include two gummies, with a total of 10mg THC + 10mg CBD per pack (5mg THC + 5mg CBD per gummy).
“Organigram continues to raise the bar with consumer-focused innovation, a key characteristic that distinguishes us in a highly competitive industry. Organigram has consistently delivered revolutionary products that go on to become consumer favourites,” said Beena Goldenberg, CEO of Organigram. “As we drive our innovation strategy to solidify our leadership in
Inspired by scientific discoveries that shape the world, Edison is here to push the barriers of what’s possible. Edison brings the joy and excitement back to cannabis – as the brand willing to wonder and willing to be playfully experimental.
Edison has a history of delivering industry-leading innovation with products like hash infused pre-rolls and first-to-market Edison JOLTS. Edison Sonics Gummies are a perfect fit within the brand’s portfolio, contributing to the ethos of the brand.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiary Organigram Inc. is a licensed producer of cannabis, cannabis-derived products and cannabis infused edibles in
Organigram is focused on producing high-quality cannabis for adult recreational consumers, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Tremblant Cannabis and Trailblazer. Organigram operates facilities in
Forward-Looking Information
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include factors and risks disclosed in the Circular, and the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR+ (see www.sedarplus.ca) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241126252025/en/
For Media enquiries:
Megan McCrae, Senior Vice President – Global Brands and Corporate Affairs
megan.mccrae@organigram.ca
For Investor Relations enquiries:
Max Schwartz, Director of Investor Relations
investors@organigram.ca
Source: Organigram Holdings Inc.
FAQ
When will Organigram (OGI) launch Edison Sonics gummies in Canada?
What is the THC and CBD content in Organigram's Edison Sonics gummies?
What is Organigram's FAST™ technology in Edison Sonics gummies?
